FLC Capital Advisors: SPY position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of FLC Capital Advisors on SPY, newest first. How the timeline and the estimate are built.
FLC Capital Advisors held 711 SPY shares at 2026-06-30 per its 13F-HR filed 2026-07-20.
the latest 13F is the newest step
- period ended2026-06-3013F 711 sharesChange vs previous 13F -315 shares
0.09% of the 13F portfolio, value $530,953.
13F-HR 0001713697-26-000004 filed by FLC Capital Advisors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 1,026 sharesChange vs previous 13F 0 shares
0.12% of the 13F portfolio, value $667,249.
13F-HR 0001713697-26-000003 filed by FLC Capital Advisors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 1,026 sharesChange vs previous 13F +597 shares
0.13% of the 13F portfolio, value $699,650.
13F-HR 0001713697-26-000002 filed by FLC Capital Advisors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 429 sharesChange vs previous 13F +25 shares
0.06% of the 13F portfolio, value $285,791.
13F-HR 0001713697-25-000005 filed by FLC Capital Advisors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 404 sharesChange vs previous 13F -45 shares
0.05% of the 13F portfolio, value $249,611.
13F-HR 0001085146-25-004263 filed by FLC Capital Advisors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 449 sharesChange vs previous 13F not available
0.06% of the 13F portfolio, value $251,166.
13F-HR 0001085146-25-002579 filed by FLC Capital Advisors
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).